NYSEARCA:CPAI Counterpoint Quantitative Equity ETF (CPAI) Price, Holdings, & News $50.65 0.00 (0.00%) As of 06/12/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock About Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CPAI alerts:Sign Up Key Stats Today's Range$50.10▼$51.0850-Day Range$42.55▼$52.0552-Week Range$35.01▼$52.08Volume143,933 shsAverage Volume50,141 shsMarket Capitalization$296.30 millionAssets Under Management$325.20 millionDividend YieldN/ANet Expense Ratio0.75%Aggregate RatingModerate Buy ETF Overview The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint. Read More Counterpoint Quantitative Equity ETF ExpensesTypeCPAIStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.65%0.47%0.57%0.51%0.53%Other Expenses0.98%0.41%0.55%0.58%0.55%Total Expense1.63%0.64%0.76%0.74%0.73%Fee Waiver-0.88%-0.46%-0.64%-0.70%-0.62%Net Expense0.75%0.53%0.63%0.58%0.60% Receive CPAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Counterpoint Quantitative Equity ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPAI ETF News HeadlinesNorthern Lights Fund Trust III - Counterpoint Quantitative Equity ETFMay 27, 2026 | money.usnews.comCPAI: Robust Performance Merits Shortlisting, But Beware Of The RisksJanuary 28, 2026 | seekingalpha.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. | Banyan Hill Publishing (Ad)Counterpoint Quantitative Equity ETF declares annual distribution of $0.3577December 16, 2025 | msn.comChina’s Market Surge: ETFs Offering Exposure to the RallyAugust 29, 2025 | theglobeandmail.comCounterpoint Tactical Equity IMay 16, 2025 | morningstar.comMSee More Headlines CPAI ETF - Frequently Asked Questions How have CPAI shares performed this year? Counterpoint Quantitative Equity ETF's stock was trading at $40.10 on January 1st, 2026. Since then, CPAI shares have increased by 26.3% and is now trading at $50.65. Who are Counterpoint Quantitative Equity ETF's major shareholders? Counterpoint Quantitative Equity ETF's top institutional shareholders include Counterpoint Mutual Funds LLC (27.77%), Cetera Investment Advisers (1.84%), Independent Financial Group LLC (1.29%) and Royal Bank of Canada (0.76%). View institutional ownership trends. How do I buy shares of Counterpoint Quantitative Equity ETF? Shares of CPAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerCounterpoint Mutual Funds, LLC Fund NameCounterpoint Quantitative Equity ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:CPAI Inception Date11/28/2023 Fund ManagerJoseph Engelberg, Michael Krause WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings51 Fund Statistics Assets Under Management$325.20 million Average Daily Volume$0.00 Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorUltimus Fund Solutions, LLC AdvisorCounterpoint Mutual Funds, LLC. CustodianBrown Brothers Harriman & Co. DistributorNorthern Lights Distributors, LLC Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerGTS Options OptionableN/A Short Interest20,300 shs Miscellaneous Outstanding Shares5,850,000Beta1.19 Creation Unit10,000 Creation Fee$200.00 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report Top 10 CPAI HoldingsAstera Labs (NASDAQ:ALAB)Holding Weight: 5.47%Micron Technology (NASDAQ:MU)Holding Weight: 4.86%Credo Technology Group (NASDAQ:CRDO)Holding Weight: 4.67%Centene (NYSE:CNC)Holding Weight: 3.20%T1 Energy (NYSE:TE)Holding Weight: 3.15%AMN Healthcare Services (NYSE:AMN)Holding Weight: 2.77%Tenable (NASDAQ:TENB)Holding Weight: 2.63%LightPath Technologies (NASDAQ:LPTH)Holding Weight: 2.57%Viavi Solutions (NASDAQ:VIAV)Holding Weight: 2.49%Adaptive Biotechnologies (NASDAQ:ADPT)Holding Weight: 2.23%Full Holdings DetailsCPAI Sector ExposureCPAI Industry Exposure This page (NYSEARCA:CPAI) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Counterpoint Quantitative Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Counterpoint Quantitative Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPAI Stock Alerts